Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar S Patel

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Journal of Cancer|November 5, 2014
Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myelomaDeanna J Fall, Holly Stessman, Sagar S Patel, et al.
Transplantation and Cellular Therapy|April 1, 2023
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-DiseaseSagar S Patel, Sanghee Hong, Lisa Rybicki, et al.
Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.
Laboratory Medicine|July 23, 2014
Early diagnosis of intravascular large B-cell lymphoma: clues from routine blood smear morphologic findingsSagar S Patel, Garth A Aasen, Michelle M Dolan, et al.
Bioinformatics Advances|March 16, 2023
promor: a comprehensive R package for label-free proteomics data analysis and predictive modelingChathurani Ranathunge, Sagar S Patel, Lubna Pinky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Blood|March 5, 2026
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDSLori S Muffly, Catherine J Lee, Arpita Gandhi, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Hematology/Oncology and Stem Cell Therapy|December 28, 2019
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Melissa Yurch, et al.
Transplantation and Cellular Therapy|March 30, 2021
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell BurdenRobert F Cornell, Raphael Fraser, Luciano Costa, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Cancer|November 5, 2014
Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myelomaDeanna J Fall, Holly Stessman, Sagar S Patel, et al.
Transplantation and Cellular Therapy|April 1, 2023
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-DiseaseSagar S Patel, Sanghee Hong, Lisa Rybicki, et al.
Hematology/Oncology and Stem Cell Therapy|October 20, 2019
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeSagar S Patel, Lisa Rybicki, Brad Pohlman, et al.
Laboratory Medicine|July 23, 2014
Early diagnosis of intravascular large B-cell lymphoma: clues from routine blood smear morphologic findingsSagar S Patel, Garth A Aasen, Michelle M Dolan, et al.
Bioinformatics Advances|March 16, 2023
promor: a comprehensive R package for label-free proteomics data analysis and predictive modelingChathurani Ranathunge, Sagar S Patel, Lubna Pinky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Blood|March 5, 2026
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDSLori S Muffly, Catherine J Lee, Arpita Gandhi, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Hematology/Oncology and Stem Cell Therapy|December 28, 2019
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Melissa Yurch, et al.
Transplantation and Cellular Therapy|March 30, 2021
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell BurdenRobert F Cornell, Raphael Fraser, Luciano Costa, et al.
Pageof 5